Lineage, Inc. Common Stock (LINE)vsReal Brokerage Inc (REAX)
LINE
Lineage, Inc. Common Stock
$42.63
-1.32%
REAL ESTATE · Cap: $11.14B
REAX
Real Brokerage Inc
$1.68
+3.70%
REAL ESTATE · Cap: $360.55M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 158% more annual revenue ($5.36B vs $2.08B). REAX leads profitability with a -0.3% profit margin vs -2.7%. REAX earns a higher WallStSmart Score of 35/100 (F).
LINE
Avoid34
out of 100
Grade: F
REAX
Hold35
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 31.5% year-over-year
Safe zone — low bankruptcy risk
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -10.0% — below average capital efficiency
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : REAX
The strongest argument for REAX centers on Revenue Growth, Altman Z-Score. Revenue growth of 31.5% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : REAX
The primary concerns for REAX are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while REAX is a hypergrowth play — different risk/reward profiles.
REAX is growing revenue faster at 31.5% — sustainability is the question.
REAX generates stronger free cash flow (23M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
REAX scores higher overall (35/100 vs 34/100) and 31.5% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.
Visit Website →Real Brokerage Inc
REAL ESTATE · REAL ESTATE SERVICES · USA
Real Brokerage Inc. is a technology-driven residential real estate brokerage company. The company is headquartered in Toronto, Canada.
Visit Website →Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?